Why I'm Avoiding 6%-Yielding Pfizer Stock

Oscar Wong/Moment via Getty Images Pfizer (NYSE:PFE) stock is an increasingly popular option for dividend growth investors due to its 14-year dividend growth streak, strong balance sheet, 6% yield, and what appears to be a deeply discounted stock price after the stock's brutal sell-off over the past two years: Data by YCharts However, I do not believe that PFE is attractive enough to warrant buying at this point, and in this article, I explain why. The Bull Case For PFE Stock  Despite facing a challengi ...